Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/Net Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 8.828.92-0.030.06-0.07

What is the latest EV/Net Sales ratio of MANKIND PHARMA ?

The latest EV/Net Sales ratio of MANKIND PHARMA is 8.82 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20258.82
Mar20248.92
Mar2023-0.03
Mar20220.06
Mar2021-0.07

How is EV/Net Sales of MANKIND PHARMA Trending?

Years EV/Net Sales % Change
Mar2025 8.82
-1.12
Mar2024 8.92
Positive
Mar2023 -0.03
Negative
Mar2022 0.06
Positive
Mar2021 -0.07 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/Net Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹85,975.9 Cr -3.4% -7.7% -20.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,991.0 Cr 0.1% -3.2% -2.6% Stock Analytics
DIVIS LABORATORIES ₹162,371.0 Cr -1.5% -7.3% 2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,229.0 Cr -1.3% -0.7% 24.4% Stock Analytics
CIPLA ₹108,441.0 Cr 1.5% -8.1% -6.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,407.0 Cr 3.2% 5.6% 3.1% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-3.4%

-7.7%

-20.3%

SENSEX

2.9%

-1.1%

8.5%


You may also like the below Video Courses